Laparoscopic sleeve gastrectomy, also known as duodenal switch, is a restrictive surgical procedure for the treatment of Crohn’s disease. It reduces the length of the large intestine and limits the number of calories that can be ingested at a time. It doesn’t bypass the intestines or decrease the absorption of nutrients. This means that the entire body of Crohn’s disease patients can benefit from this procedure.
How Laparoscopic Sleeve Gastrectomy (RYGBP) Can Reduce the Belly Fat in Crohn’s Disease
Laparoscopic sleeve gastrectomy can help treat Crohn’s disease due to its focus on reducing the excessive body mass index (BMI), which is a risk factor for many inflammatory diseases. Patients with excessive belly fat have a greater risk of developing diarrhea, irritable bowel syndrome, and ulcerative colitis. By reducing the belly fat, the patient’s health can improve, as well as dramatically reduce their risk of developing one of these inflammatory conditions. This procedure is also used to treat patients who are morbidly obese, as excess body weight increases the risks of heart disease and other health complications.
Because there is a greater curvature of the stomach than in other forms of invasive surgery, laparoscopic sleeve gastrectomy offers a more rapid return to health after surgery. Because the surgery takes only about 15 minutes, there is no recovery time needed. Patients are released from hospital care and can go home to their families in about two hours. Patients can return to work in a week or so, and can return to their normal activity level within a few weeks.